Yuankui Cao

No ORCID on file · 1 paper in corpus
article 2015
Journal of clinical pharmacology ·doi:10.1002/jcph.485

Seventy patients with stage III or IV endometriosis were randomly assigned to 2 groups after conservative surgery. Group O (n = 35) received 3 cycles of a 28-day gonadotropin-releasing hormone agonist (GnRH-a) treatment (goserelin, 3.6 mg) …